F
Francesca Tentori
Researcher at Vanderbilt University
Publications - 47
Citations - 3465
Francesca Tentori is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Dialysis & Hemodialysis. The author has an hindex of 22, co-authored 47 publications receiving 2819 citations. Previous affiliations of Francesca Tentori include DaVita & Vanderbilt University Medical Center.
Papers
More filters
Journal ArticleDOI
Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori,Margaret J. Blayney,Justin M. Albert,Brenda W. Gillespie,Peter G. Kerr,Jürgen Bommer,Eric W. Young,Tadao Akizawa,Takashi Akiba,Ronald L. Pisoni,Bruce M. Robinson,Friedrich K. Port +11 more
TL;DR: The results provide important information about mineral metabolism trends in hemodialysis patients in 12 countries during a decade and may be relevant to efforts at international harmonization of existing clinical guidelines for mineral metabolism.
Journal ArticleDOI
High rates of death and hospitalization follow bone fracture among hemodialysis patients
Francesca Tentori,Keith McCullough,Ryan D. Kilpatrick,Brian D. Bradbury,Brian D. Bradbury,Bruce M. Robinson,Peter G. Kerr,Ronald L. Pisoni +7 more
TL;DR: The high frequency of fractures and increased adverse outcomes following a fracture pose a significant health burden for dialysis patients and Fracture prevention strategies should be identified and applied broadly in nephrology practices.
Journal ArticleDOI
Worldwide, mortality risk is high soon after initiation of hemodialysis
Bruce M. Robinson,Jinyao Zhang,Hal Morgenstern,Brian D. Bradbury,Brian D. Bradbury,Leslie J Ng,Keith McCullough,Brenda W. Gillespie,Raymond M. Hakim,Hugh C. Rayner,Joan Fort,Tadao Akizawa,Francesca Tentori,Ronald L. Pisoni +13 more
TL;DR: The early hemodialysis period is a high-risk time for all countries studied, with substantial differences in mortality between countries, and efforts to improve outcomes should focus on the transition period and first few months of dialysis.
Journal ArticleDOI
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Francesca Tentori,Mia Wang,Brian Bieber,Angelo Karaboyas,Yun Li,Stefan H. Jacobson,Vittorio E. Andreucci,Masafumi Fukagawa,Luc Frimat,David C. Mendelssohn,Friedrich K. Port,Ronald L. Pisoni,Bruce M. Robinson +12 more
TL;DR: In a large international sample of patients on hemodialysis, parathyroid hormone levels increased in most countries, and secondary hyperparathyroidism treatments changed over time, and very low and very high parathyro hormone levels were associated with adverse outcomes.
Journal ArticleDOI
Recovery Time, Quality of Life, and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Hugh C. Rayner,Lindsay Zepel,Douglas S. Fuller,Hal Morgenstern,Angelo Karaboyas,Bruce F. Culleton,Donna Mapes,Antonio Alberto Lopes,Brenda W. Gillespie,Takeshi Hasegawa,Rajiv Saran,Francesca Tentori,Manfred Hecking,Ronald L. Pisoni,Bruce M. Robinson +14 more
TL;DR: Recovery time can be used to identify patients with poorer HRQoL and higher risks of hospitalization and mortality and Interventions to reduce recovery time and possibly improve clinical outcomes, such as increasing dialysate sodium concentration, need to be tested in randomized trials.